MedTrace Logo

Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps

NCT06376565 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1680

Last updated 2025-11-14

No results posted yet for this study

Summary

This clinical trial tests a multilevel intervention at the clinic, provider and patient levels, to improve colonoscopy surveillance in patients with high risk colon polyps. Colorectal cancer (CRC) is a common and deadly disease that is largely preventable through the detection and removal of colorectal polyps. One million Americans are diagnosed with high risk polyps of the colon or rectum annually and are at increased risk for CRC; however, uptake of recommended repeat colonoscopy in 3 years to reduce CRC risk is low in this group. This multilevel intervention may work to improve timely colonoscopy screening for patients with high risk colon polyps.

Conditions

  • Colorectal Carcinoma

Interventions

OTHER

Best Practice

Receive standard care

OTHER

Communication Intervention

Complete clinic EHR interventions

OTHER

Communication Intervention

Receive scheduling reminders

OTHER

Communication Intervention

Receive reminders and pending EHR orders

OTHER

Interview

Complete interview

OTHER

Interview

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Folasade P May · UCLA / Jonsson Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-08
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06376565 on ClinicalTrials.gov